logo
logo

S-Alpha Therapeutics, Inc., Digital Therapeutics Start-Up Raises $8.7 Million In Series A Funding

S-Alpha Therapeutics, Inc., Digital Therapeutics Start-Up Raises $8.7 Million In Series A Funding

08/09/21, 4:54 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/KR.svgseoul
Money raised
$8.7 million
Round Type
series a
On July 31st 2021, S-Alpha Therapeutics, Inc., (“S-Alpha” CEO: Seung-Eun Choi), a startup dedicated in R&D for digital therapeutics, announced the completion of its Series A financing.

Company Info

Company
S Alpha Therapeutics
Location
seoul, seoul, south korea
Additional Info
Founded in 2019, S-Alpha Therapeutics develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology. Company has developed several digital therapeutic products in its R&D pipeline. Currently, company is conducting clinical trials to evaluate the efficacy, safety and feasibility of SAT-001 in several clinical sites in South Korea. Among the company's pipelines, SAT-008, developed for the purpose of inducing an individual's immune-boosting effect, is in the process of establishing a business development model according to the evidence generated from clinical studies in South Korea. In addition, S-Alpha Therapeutics is in the process of developing other products in the pipeline. www.salphadtx.com